Novartis' Narasimhan ‘completely blindsided’ by Cohen deal by Angus Liu Friday, November 30, 2018 The Novartis CEO said he was "completely blindsided" by news of the $1.2 million payment to Michael Cohen after just three months on the job.
Novartis loses top oncology exec Strigini to retirement by Eric Sagonowsky Friday, December 15, 2017 As Novartis preps for its upcoming CEO transition, so too will it have to find a new leader in oncology.
Novartis eyes markets new to performance-based pricing by Eric Sagonowsky Thursday, October 5, 2017 Novartis is only in the very early days of its Kymriah rollout in the U.S., but company executives aren't only focusing on the States.
Novartis CEO says most biotech deals are just too expensive by Eric Sagonowsky Wednesday, July 19, 2017 Novartis is hunting for bolt-on deals, but too-high biotech valuations have forced its M&A scouts to eye early-stage assets.
Roche, Novartis CEOs rack up matching 2016 pay by Tracy Staton Wednesday, March 1, 2017 Roche CEO Severin Schwan and Novartis chief Joe Jimenez likely won't rank among biopharma's highest-paid this year. But at least they're on par with each other at almost 12M francs each.
